Case File
efta-efta00933709DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00933709
Pages
4
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: "Barrett, Paul S"
Subject: Re: Brent pricing
Date: Tue, 01 May 2012 13:47:03 +0000 yes
On Tue, May 1, 2012 at 9:45 AM, Barrett, Paul S <
OK — can I execute?
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
From: Jeffrey Epstein [mailto:jeevacation gmail.corn]
Sent: Tuesday, May 01, 2012 9:42 AM
To: Barrett, Paul S
Subject: Re: Brent pridng
> wrote:
keep
On Tue, May 1, 2012 at 9:36 AM, Barrett, Paul S < wrote:
So confirm — you would like to do the Sept contract on 250,000 barrels. Would you like to keep the premium or rather
go cashless and increase the notional on the upside?
EFTA00933709
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
From: Jeffrey Epstein [rnailto:jeeyacation grnail.corn]
Sent: Tuesday, May 01, 2012 9:33 AM
To: Barrett, Paul S
Subject: Re: Brent pricing no benefit to do aug
On Tue, May 1, 2012 at 9:30 AM, Barrett, Paul S
Jeffrey
Why don't we do 125,000 barrels of each date. Spread it out a little.
Bullish Brent risk reversals
August 2012 contract (11Jul2012 expiry)
118.30 reference
1) client buys 140 call
2) client sells 100 put
> wrote:
EFTA00933710
Net premium: client receives $0.05/bbl
September 2012 contract (13Aug2012 expiry)
117.85 reference
1) client buys 140 call
2) client sells 100 put
Net premium: client receives $0.29/bbl
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
(W)
(F)
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
EFTA00933711
communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00933712
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.